These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11293444)

  • 1. Relationships between haemodynamic alterations and the development of ascites or refractory ascites in patients with cirrhosis.
    Colle I; Moreau R; Pessione F; Rassiat E; Heller J; Chagneau C; Pateron D; Barrière E; Condat B; Sogni P; Valla D; Lebrec D
    Eur J Gastroenterol Hepatol; 2001 Mar; 13(3):251-6. PubMed ID: 11293444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin, aldosterone and renal haemodynamics in cirrhosis with ascites.
    Arroyo V; Bosch J; Mauri M; Viver J; Mas A; Rivera F; Rodes J
    Eur J Clin Invest; 1979 Feb; 9(1):69-73. PubMed ID: 110603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal hemodynamics in patients with cirrhosis: relationship with ascites and liver failure.
    Moreau R; Gaudin C; Hadengue A; Braillon A; Roulot D; Bacq Y; Lebrec D
    Nephron; 1993; 65(3):359-63. PubMed ID: 8289984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.
    Wong F; Raina N; Richardson R
    Gut; 2010 Mar; 59(3):381-6. PubMed ID: 19710033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Angeli P; Volpin R; Piovan D; Bortoluzzi A; Craighero R; Bottaro S; Finucci GF; Casiglia E; Sticca A; De Toni R; Pavan L; Gatta A
    Hepatology; 1998 Oct; 28(4):937-43. PubMed ID: 9755229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal haemodynamics in patients with liver cirrhosis assessed by colour ultrasonography.
    Wang Y; Liu LP; Bai WY; Wen SB; Dan HJ; Luan YY; Zeng MX; Hu B
    J Int Med Res; 2011; 39(1):249-55. PubMed ID: 21672328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
    Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
    Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-selective beta-blockers impair global circulatory homeostasis and renal function in cirrhotic patients with refractory ascites.
    Téllez L; Ibáñez-Samaniego L; Pérez Del Villar C; Yotti R; Martínez J; Carrión L; Rodríguez de Santiago E; Rivera M; González-Mansilla A; Pastor Ó; Bermejo J; Bañares R; Albillos A
    J Hepatol; 2020 Dec; 73(6):1404-1414. PubMed ID: 32446716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites.
    Wong F; Sniderman K; Liu P; Allidina Y; Sherman M; Blendis L
    Ann Intern Med; 1995 Jun; 122(11):816-22. PubMed ID: 7741365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of renal cortical blood flow assessed by Doppler in cirrhotic patients with refractory ascites.
    Rivolta R; Maggi A; Cazzaniga M; Castagnone D; Panzeri A; Solenghi D; Lorenzano E; di Palo FQ; Salerno F
    Hepatology; 1998 Nov; 28(5):1235-40. PubMed ID: 9794906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natriuretic response to the combination of atrial natriuretic peptide and terlipressin in patients with cirrhosis and refractory ascites.
    Gadano A; Moreau R; Vachiery F; Soupison T; Yang S; Cailmail S; Sogni P; Hadengue A; Durand F; Valla D; Lebrec D
    J Hepatol; 1997 Jun; 26(6):1229-34. PubMed ID: 9210608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of single dose of 50mg captopril in patients with liver cirrhosis and ascites.
    Lee JK; Hsieh JF; Tsai SC; Ho YJ; Kao CH
    Hepatogastroenterology; 2000; 47(33):767-70. PubMed ID: 10919029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal functional reserve is well maintained in patients with advanced liver cirrhosis and ascites.
    Woitas RP; Flommersfeld S; Stoffel-Wagner B; Schiedermaier P; Brensing KA; Spengler U; Sauerbruch T
    Scand J Gastroenterol; 2002 Nov; 37(11):1321-7. PubMed ID: 12465732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Portal and systemic hemodynamics and humoral factors in cirrhosis with and without ascites.
    Hayes PC; Cumming AD; Craig KJ; Watson M; Bouchier IA
    Am J Gastroenterol; 1992 Oct; 87(10):1433-8. PubMed ID: 1415100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
    Hadengue A; Moreau R; Bacq Y; Gaudin C; Braillon A; Lebrec D
    Hepatology; 1991 Jan; 13(1):111-6. PubMed ID: 1671029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of narcotic agents and of bleeding on systemic and renal haemodynamics in healthy and CCl4-treated cirrhotic rats.
    Van Roey G; Lijnen P; Verbesselt R; Verbruggen A; Fevery J
    Clin Sci (Lond); 1997 Dec; 93(6):549-56. PubMed ID: 9497792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral probiotic VSL#3 attenuates the circulatory disturbances of patients with cirrhosis and ascites.
    Rincón D; Vaquero J; Hernando A; Galindo E; Ripoll C; Puerto M; Salcedo M; Francés R; Matilla A; Catalina MV; Clemente G; Such J; Bañares R
    Liver Int; 2014 Nov; 34(10):1504-12. PubMed ID: 24661740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.
    Salerno F; Guevara M; Bernardi M; Moreau R; Wong F; Angeli P; Garcia-Tsao G; Lee SS
    Liver Int; 2010 Aug; 30(7):937-47. PubMed ID: 20492521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
    Tan HK; James PD; Wong F
    Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.